Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Godavari Biorefineries rises after expanding ethanol capacity at Karnataka distillery
Godavari Biorefineries advanced 1.67% to Rs 282.80 after the company announced that it has commenced a corn / grain-based distillery at its Sameerwadi Unit, Karnataka, aimed at meeting the rising demand under India's ethanol blending program.
Godavari Biorefineries rallies after securing Japanese patent for cancer treatment
Godavari Biorefineries rallied 6.95% to Rs 303.90 after the company announced that the japanese patent office had granted a patent for its invention, 5-Hydroxy-1,4-Naphthalenedione, for use in the treatment of cancer.
Godavari Biorefineries receives Japanese patent
For a novel class of compounds used in treatment of Cancer
Godavari Biorefineries shares rises 10% on Japanese patent for cancer treatment invention
Godavari Biorefineries said the patented invention relates to the use of 5-Hydroxy-1,4-Naphthalenedione in the treatment of cancer and strengthens its intellectual property portfolio in the healthcare and life sciences space.
Concurrent Losers: 14 smallcap stocks decline for 5 consecutive sessions
Amid broader market weakness, the Sensex fell 408 points over five sessions ending May 29, while 14 BSE smallcap stocks declined continuously, losing up to 15% led by Wakefit Innovations, Master Trust and Godavari Biorefineries.
Godavari Biorefineries consolidated net profit declines 26.48% in the March 2026 quarter
Sales decline 2.66% to Rs 564.10 crore
Care Ratings reaffirms ratings of Godavari Biorefineries at 'BBB+/A2' with 'stable' outlook
Godavari Biorefineries said that Care Ratings has reaffirmed the company's long-term rating at 'CARE BBB+' with 'stable' outlook.